close
close
“Dallas Stars Focus on Long-Term After Upcoming Surgery”

The Dallas Stars have been turning up the intensity lately and a large part of their continued success is due to forward Tyler Seguin. The 32-year-old scorer had another strong start to the 2024-2025 season, scoring nine goals and 20 points in 19 games.

Unfortunately for the Stars and Seguin, his impressive start won’t continue over the next few months. After recently placing the star on Injured Reserve, the news took a turn for the worse when general manager Jim Nill announced that Seguin would undergo surgery to repair issues with his left hip labrum and femoral acetabular impingement (FAI). The pending proceedings will keep him away from regular deployment for four to six months.

Losing Seguin is a huge blow. Not only does this deprive the team of one of its best offensive players, it also forces the team to revamp its forward line, a group that has been clicking at every level of late. Seguin was one third of a dynamic trio that made up the Stars’ second line. Along with Mason Marchment and Matt Duchene, they were each on a points per game pace to start the season.

Now the Stars will once again try to spread the responsibility and scoring load without Seguin. The team has players to turn to, particularly young players like Logan Stankoven and Mavrik Bourque, and will likely receive an increase in playing time due to Seguin’s absence. But as talented as their young players are, none of them have the experience and qualifications that the experienced Seguin has acquired.

Meanwhile, the Stars are still one of the top teams in the Central Division with a record of 16-8. Without one of their top scorers, their front office could look outside the organization for reinforcements, but the team’s exact plan to overcome this latest obstacle remains a mystery.

Be sure to bookmark Breakaway OnSI for the latest news, exclusive interviews, recruiting reports and more!

Leave a Reply

Your email address will not be published. Required fields are marked *